I. Maruyama et al., Normal expression levels of cathepsins, protease inhibitors, and Sp1 in conjunctival tissues from patients with keratoconus, CURR EYE R, 21(5), 2000, pp. 886-890
Purpose. In keratoconus corneas, it has been shown that levels of degradati
ve enzymes and transcription factor Sp1 are elevated and those of inhibitor
s are reduced, especially in the epithelial layer. This study is to determi
ne whether the biochemical abnormalities identified in corneas also exist i
n conjunctival tissues.
Methods. Conjunctival tissues were collected from normal subjects and from
patients with keratoconus, senile cataract, and other corneal diseases. Imm
unohistochemical staining for cathepsins B and G, alpha1-proteinase inhibit
or, alpha2-macroglobulin and Sp1 was performed.
Results. The epithelium of all conjunctival specimens showed immunoreactivi
ty toward the antibodies. The staining for cathepsins B and G, and the inhi
bitors was mostly cytoplasmic, while that for Sp1 was nuclear. The staining
intensity in keratoconus specimens was all within normal range.
Conclusions. These results suggest that the abnormalities in cathepsins B a
nd G, protease inhibitors and Sp1 identified in keratoconus corneas are not
manifested in the conjunctiva. Keratoconus appears to be a disease localiz
ed to the cornea.